Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01425697 · ClinicalTrials.gov registry record · NA
Eliminate Risk of Cardiac Surgical Site Events
A NA study of Surgical Site Infections, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 739
- Enrollment target
- 4
- Study locations
NCT01425697 is a NA study of Surgical Site Infections that has completed, run by University of Rochester. The registered enrollment target is 739 participants, below the 1,641-participant average among 3 other Surgical Site Infections trials with a reported enrollment target (55% lower). The trial reports 4 study locations across 4 states.
The verdict
NCT01425697, a NA study of Surgical Site Infections, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 739 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of the study is to see if using 2% Chlorhexidine cloths will reduce surgical site infections in patients having elective cardiac surgery.
Conditions Studied
Interventions
- OTHER 2% Chlorhexidine Gluconate cloths
- OTHER Standard of Care preoperative preparation.
Study Locations (4)
Kentucky
- University of Kentucky - Lexington
New Jersey
- The Valley Hospital - Ridgewood
New York
- University of Rochester Medical Center - Rochester
Pennsylvania
- Robert Packer Hospital - Sayre
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 739 participants |
| Start Date | 2008-11 |
| Est. Completion | 2012-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01425697
The ClinicalTrials.gov registry entry for NCT01425697 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 739 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,641-participant average among 3 other Surgical Site Infections trials with a reported enrollment target (55% lower). The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Surgical Site Infections appearing as the primary indexed condition, and to 2 interventions - of which 2% Chlorhexidine Gluconate cloths is the first listed.
NCT01425697 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Kentucky, New Jersey, New York.
Frequently Asked Questions
What is clinical trial NCT01425697 about?
NCT01425697 is a clinical study titled "Eliminate Risk of Cardiac Surgical Site Events". The purpose of the study is to see if using 2% Chlorhexidine cloths will reduce surgical site infections in patients having elective cardiac surgery.
What is the current status of trial NCT01425697?
This trial is currently completed. It is a NA study. The enrollment target is 739 participants. The study started on 2008-11. Estimated completion is 2012-09.
What conditions does trial NCT01425697 study?
This clinical trial studies the following conditions: Surgical Site Infections.
What interventions are being tested in trial NCT01425697?
The interventions under investigation include: 2% Chlorhexidine Gluconate cloths (OTHER), Standard of Care preoperative preparation. (OTHER).
Who is sponsoring clinical trial NCT01425697?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01425697 being conducted?
This trial has 4 study locations across Kentucky, New Jersey, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Surgical Site Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effectiveness of Screening and Decolonization of S. Aureus to Prevent S. Aureus Surgical Site Infections in Surgery Outpatients
RECRUITING
-
Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections
RECRUITING · Phase 3
-
2% Chlorhexidine Gluconate Skin Cloths to Prevent SSI in Spine Surgery Patients
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.